Ausgabe 2/2012
Animal Models of Neurological Disorders
Inhalt (20 Artikel)
Novel Animal Models of Pediatric Epilepsy
Stéphane Auvin, Eduardo Pineda, Don Shin, Pierre Gressens, Andrey Mazarati
Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
Veronica F. Colomer Gould
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Marie-Francoise Chesselet, Franziska Richter, Chunni Zhu, Iddo Magen, Melanie B. Watson, Sudhakar R. Subramaniam
Genetic Manipulation of Cell Death and Neuroplasticity Pathways in Traumatic Brain Injury
Kathleen M. Schoch, Sindhu K. Madathil, Kathryn E. Saatman
Accelerating Discovery for Complex Neurological and Behavioral Disorders Through Systems Genetics and Integrative Genomics in the Laboratory Mouse
Jason A. Bubier, Elissa J. Chesler
Models That Matter: White Matter Stroke Models
Elif G. Sozmen, Jason D. Hinman, S. Thomas Carmichael
The Instrumented Fetal Sheep as a Model of Cerebral White Matter Injury in the Premature Infant
Stephen A. Back, Art Riddle, Justin Dean, A. Roger Hohimer
Nonhuman Primate Models of Stroke for Translational Neuroprotection Research
Douglas J. Cook, Michael Tymianski
Animal Models of Neurologic Disorders: A Nonhuman Primate Model of Spinal Cord Injury
Yvette S. Nout, Ephron S. Rosenzweig, John H. Brock, Sarah C. Strand, Rod Moseanko, Stephanie Hawbecker, Sharon Zdunowski, Jessica L. Nielson, Roland R. Roy, Gregoire Courtine, Adam R. Ferguson, V. Reggie Edgerton, Michael S. Beattie, Jacqueline C. Bresnahan, Mark H. Tuszynski
A Predictable Worm: Application of Caenorhabditis elegans for Mechanistic Investigation of Movement Disorders
Paige M. Dexter, Kim A. Caldwell, Guy A. Caldwell
CR8, a Selective and Potent CDK Inhibitor, Provides Neuroprotection in Experimental Traumatic Brain Injury
Shruti V. Kabadi, Bogdan A. Stoica, Marie Hanscom, David J. Loane, Giorgi Kharebava, Michael G. Murray II, Rainier M. Cabatbat, Alan I. Faden
Effects of Olig2-Overexpressing Neural Stem Cells and Myelin Basic Protein-Activated T Cells on Recovery from Spinal Cord Injury
Jian-Guo Hu, Lin Shen, Rui Wang, Qi-Yi Wang, Chen Zhang, Jin Xi, Shan-Feng Ma, Jian-Sheng Zhou, He-Zuo Lü
Recovery of MERRF Fibroblasts and Cybrids Pathophysiology by Coenzyme Q10
Mario De la Mata, Juan Garrido-Maraver, David Cotán, Mario D. Cordero, Manuel Oropesa-Ávila, Lourdes Gómez Izquierdo, Manuel De Miguel, Juan Bautista Lorite, Eloy Rivas Infante, Patricia Ybot, Sandra Jackson, José A. Sánchez-Alcázar
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo
Shubhangi Prabhudesai, Sharmistha Sinha, Aida Attar, Aswani Kotagiri, Arthur G. Fitzmaurice, Ravi Lakshmanan, Magdalena I. Ivanova, Joseph A. Loo, Frank-Gerrit Klärner, Thomas Schrader, Mark Stahl, Gal Bitan, Jeff M. Bronstein
Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression
Eduardo A. Pineda, Julie G. Hensler, Raman Sankar, Don Shin, Teresa F. Burke, Andréy M. Mazarati
Erratum to: A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity In Vitro and In Vivo
Shubhangi Prabhudesai, Sharmistha Sinha, Aida Attar, Aswani Kotagiri, Arthur G. Fitzmaurice, Rajeswari Lakshmanan, Magdalena I. Ivanova, Joseph A. Loo, Frank-Gerrit Klärner, Thomas Schrader, Mark Stahl, Gal Bitan, Jeff M. Bronstein